BIOHAVEN PHARMACEUTICAL

Biohaven is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV3000-301, BHV3000-302, BHV3000-303, and others.

#SimilarOrganizations #People #Financial #Website #More

BIOHAVEN PHARMACEUTICAL

Social Links:

Facebook

Twitter

Instagram

Youtube

Industry:

Biotechnology Health Care Health Diagnostics Neuroscience Pharmaceutical

Founded:

2013-01-01

Address:

New Haven, Connecticut, United States

Country:

United States

Website Url:

http://www.biohavenpharma.com

Total Employee:

1001+

Status:

Active

Total Funding:

443.7 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Tag Manager Font Awesome Mobile Non Scaleable Content IPv6 Google Maps ReCAPTCHA Cloudflare JS CDN JS

Similar Organizations

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

idera-pharmaceuticals-logo

Idera Pharmaceuticals

Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.

Current Advisors List

declan-doogan_image

Declan Doogan Chairman of the Board of Directors @ Biohaven Pharmaceutical
Board_member

julia-gregory_image

Julia Gregory Member Board Of Directors, Audit Committee Chair @ Biohaven Pharmaceutical
Board_member
2017-08-01

john-w-childs_image

John W. Childs Board o Directors @ Biohaven Pharmaceutical
Board_member

vlad-coric_image

Vlad Coric Board o Directors @ Biohaven Pharmaceutical
Board_member

Current Employees Featured

rob-berman_image

Rob Berman
Rob Berman Executive Officer & Co-Founder, Special Projects & Medical Oversight @ Biohaven Pharmaceutical
Executive Officer & Co-Founder, Special Projects & Medical Oversight
2019-01-01

james-engelhart_image

James Engelhart
James Engelhart Chief Financial Officer @ Biohaven Pharmaceutical
Chief Financial Officer
2016-05-01

charles-conway_image

Charles Conway
Charles Conway Chief Scientific Officer @ Biohaven Pharmaceutical
Chief Scientific Officer
2017-01-01

william-bj-jones_image

William "BJ" Jones
William "BJ" Jones Chief Commercial Officer, Migraine & Common Diseases @ Biohaven Pharmaceutical
Chief Commercial Officer, Migraine & Common Diseases
2019-04-01

vlad-coric_image

Vlad Coric
Vlad Coric Chief Executive Officer @ Biohaven Pharmaceutical
Chief Executive Officer
2015-10-01

azim-munivar_image

Azim Munivar
Azim Munivar Medical Director @ Biohaven Pharmaceutical
Medical Director

elyse-stock_image

Elyse Stock
Elyse Stock Chief Medical Officer @ Biohaven Pharmaceutical
Chief Medical Officer
2019-01-01

robert-croop_image

Robert Croop
Robert Croop Chief Development Officer, Neurology @ Biohaven Pharmaceutical
Chief Development Officer, Neurology
2017-01-01

john-tilton_image

John Tilton
John Tilton Chief Commercial Officer @ Biohaven Pharmaceutical
Chief Commercial Officer
2016-04-01

cliff-bechtold_image

Cliff Bechtold
Cliff Bechtold Chief Operating Officer @ Biohaven Pharmaceutical
Chief Operating Officer
2017-10-01

Founder

rob-berman_image

Rob Berman

Stock Details

Company's stock symbol is NYSE:BHVN

Acquisitions List

Date	Company	Article	Price
2021-01-07	Kleo	Kleo acquired by Biohaven Pharmaceutical	20 M USD

Investors List

soros-fund-management_image

Investments List

Date	Company	Article	Money raised
2021-03-01	Artizan Biosciences	Biohaven Pharmaceutical investment in Series A - Artizan Biosciences	18.88 M USD
2018-11-14	Kleo	Biohaven Pharmaceutical investment in Series B - Kleo	21 M USD
2016-09-01	Kleo	Biohaven Pharmaceutical investment in Series A - Kleo	N/A

Official Site Inspections

http://www.biohavenpharma.com Semrush global rank: 1.11 M Semrush visits lastest month: 29.03 K

Host Informations
Whois Informations

Loading ...